Eledon Pharmaceuticals
ELDN
NASDAQ
IPO2014
about ELDN
Eledon Pharmaceuticals is a biopharmaceutical company developing RNA-based therapies for rare diseases using innovative chimeric antisense oligonucleotide technology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.09 | $4.25 | $3.78 | $241.32M | 4.03M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.13 | n/a | n/a | 0% | 0% | 0% |